Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma

Clinical trial NCT00614042 · COMPLETED

Trial details

NCT number: NCT00614042
Sponsor: Aptevo Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL)

Start date: 2008-01-01
Primary completion: 2011-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.